Journal
CYTOKINE & GROWTH FACTOR REVIEWS
Volume 41, Issue -, Pages 28-39Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2018.03.006
Keywords
Oncolytic viruses; Immune therapy; Transgenes
Categories
Funding
- Stichting Technische Wetenschappen [15414]
- foundation overleven met alvleesklierkanker
Ask authors/readers for more resources
Oncolytic viruses (OVs), viruses that specifically result in killing tumor cells, represent a promising class of cancer therapy. Recently, the focus in the OV therapy field has shifted from their direct oncolytic effect to their immune stimulatory effect. OV therapy can function as a kick start for the antitumor immune response by releasing tumor associated antigens and release of inflammatory signals. Combining OVs with immune modulators could enhance the efficacy of both immune and OV therapies. Additionally, genetic engineering of OVs allows local expression of immune therapeutics, thereby reducing related toxicities. Different options to modify the tumor microenvironment in combination with OV therapy have been explored. The possibilities and obstacles of these combinations will be discussed in this review.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available